![Neal Fowler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neal Fowler
Directeur/Membre du Conseil chez
EMERGENT BIOSOLUTIONS INC.
Fortune : 1 M $ au 30/06/2026
Profil
Mr. Neal F.
Fowler is an Independent Director at Emergent BioSolutions, Inc., a Chairman at NC Life Sciences Organization, a Chief Executive Officer & Director at Pathalys Pharma, Inc. and an Operating Partner at Catalys Pacific LLC.
He is on the Board of Directors at Emergent BioSolutions, Inc., Pathalys Pharma, Inc. and The North Carolina Biotechnology Center.
Mr. Fowler was previously employed as a Chief Executive Officer & Director by Liquidia Corp., a Chief Executive Officer & Director by Envisia Therapeutics, Inc., an Independent Director by Aralez Pharmaceuticals, Inc., an Independent Director by POZEN, Inc., a President by Liquidia Technologies, Inc., a President by Centocor, Inc., a President by Ortho-mcneil Neurologics, Inc., a Vice President by Ortho-McNeil Pharmaceutical, Inc., a Director-Sales & Marketing by Eli Lilly & Co., a President by Johnson & Johnson, and a Chairman by Unc Eshelman School of Pharmacy Foundation.
He received his undergraduate degree from the University of North Carolina at Chapel Hill and an MBA from the University of North Carolina at Chapel Hill.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/04/2026 | 160 847 ( 0,31 % ) | 1 M $ | 30/06/2026 |
Postes actifs de Neal Fowler
| Sociétés | Poste | Début |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Directeur/Membre du Conseil | 28/09/2023 |
NC Life Sciences Organization
 NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services Focuses primarily on legislative monitoring and lobbying activities at the state and federal level | Président | - |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services Provides research and education grants | Directeur/Membre du Conseil | - |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific invests in companies located in Cayman Islands. The firm targets companies operating in the fields of health services and health technology. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. BiotechnologyHealth Technology Operates as late-stage clinical biopharmaceutical company that develops therapeutics for chronic kidney disease | Directeur Général | - |
Anciens postes connus de Neal Fowler
| Sociétés | Poste | Fin |
|---|---|---|
| LIQUIDIA CORPORATION | Directeur Général | 14/12/2020 |
| OLD API WIND-DOWN LTD. | Directeur/Membre du Conseil | 10/08/2018 |
| POZEN INC. | Directeur/Membre du Conseil | 01/02/2016 |
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel ocular therapies | Fondateur | 01/01/2015 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Neal Fowler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops therapeutics for diseases | Health Technology |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services Provides research and education grants | Technology Services |
NC Life Sciences Organization
NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services Focuses primarily on legislative monitoring and lobbying activities at the state and federal level | Commercial Services |
Envisia Therapeutics, Inc.
Envisia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel ocular therapies | Health Technology |
Ortho-mcneil Neurologics, Inc. | |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Catalys Pacific LLC
Catalys Pacific LLC Investment ManagersFinance Catalys Pacific invests in companies located in Cayman Islands. The firm targets companies operating in the fields of health services and health technology. It provides financing for early stage capital requirements. | Finance |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Unc Eshelman School of Pharmacy Foundation | |
University of North Carolina at Chapel Hill
 University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. BiotechnologyHealth Technology Operates as late-stage clinical biopharmaceutical company that develops therapeutics for chronic kidney disease | Health Technology |
